MCM2 and endometrioid adenocarcinoma: Figure 1 shows the hematoxylin and eosin (H&E) staining features (Figure 1A, 1C, 1E, 1G) and expression patterns of MCM2 in serous carcinoma, endometrioid carcinoma, and clear cell carcinoma using the monoclonal antibody BM28.